Evidence map›Paper›PMID 42731989›Full record

ArticleMolecular psychiatry2026

PQBP1-dependent alternative RNA splicing underlies high calorie diet-induced cognitive impairment.

Yong Huang, Hidenori Homma, Yuki Yoshioka, Takaki Watanabe, Shuhei Fujino, Kyoko Matsuyama, Xigui Chen, Kyota Fujita, Hiroki Shiwaku, Albert R La Spada and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Yong Huang *Center for Brain Integration Research, Institute of Science Tokyo, 2-3-10, Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan.
Hidenori Homma *Center for Brain Integration Research, Institute of Science Tokyo, 2-3-10, Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan.ORCID http://orcid.org/0000-0003-3175-7463
Yuki Yoshioka *Center for Brain Integration Research, Institute of Science Tokyo, 2-3-10, Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan.ORCID http://orcid.org/0000-0002-7931-0313
Takaki WatanabeDepartment of Neurophysiology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.ORCID http://orcid.org/0000-0001-8746-1683
Shuhei FujinoDepartment of Neurophysiology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Kyoko MatsuyamaDepartment of Neurophysiology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Xigui ChenCenter for Brain Integration Research, Institute of Science Tokyo, 2-3-10, Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan.
Kyota FujitaCenter for Brain Integration Research, Institute of Science Tokyo, 2-3-10, Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan.ORCID http://orcid.org/0000-0001-8384-8143
Hiroki ShiwakuDepartment of Psychiatry, Institute of Science Tokyo, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.ORCID http://orcid.org/0000-0001-7503-8044
Albert R La SpadaDepartments of Pathology and Laboratory Medicine, Neurology, Biological Chemistry, and Neurobiology & Behavior, University of California Irvine, Irvine, CA 92697, USA; and UCI Center for Neurotherapeutics, University of California Irvine, Irvine, CA, 92697, USA.
Masanobu KanoDepartment of Neurophysiology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.ORCID http://orcid.org/0000-0002-0725-3292
Hikari Tanaka *Center for Brain Integration Research, Institute of Science Tokyo, 2-3-10, Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan.
Hitoshi OkazawaCenter for Brain Integration Research, Institute of Science Tokyo, 2-3-10, Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan. okazawa.npat@mri.tmd.ac.jp.ORCID http://orcid.org/0000-0002-6127-5046

Funding

Japan Agency for Medical Research and Development (AMED) 3gm1910001h0001, 23gm1910001h0002, Brain/MINDSMEXT | Japan Society for the Promotion of Science (JSPS) 21ek0109527s0201, 22ek0109527s0202, 23ek0109527s0203Ministry of Education, Culture, Sports, Science and Technology (MEXT) a Grant-in-Aid for Scientific Research on Innovative Areas
6 · The paper itself

Abstract

High calorie-high fat diet (HFD) has been implicated as a pathological modifier of brain diseases including neurodegenerative dementias, but the detailed molecular mechanisms remain largely unknown. Here we report that HFD suppresses PPARγ-mediated transcriptional expression of PQBP1, a RNA splicing factor implicated in human intellectual disability and Alzheimer's disease. RNAseq-based comprehensive analyses of alternative RNA splicing (AS) in HFD-fed mice for 1 or 6 weeks and in PQBP1-cKO mice reveal their common changes, which weigh on synapse-related genes. Betweenness-based extraction of core molecules from the common changes reveals CASK, Cacnb1 and Cyfip2 as key molecules of the network. Both CASK and Cacnb1 regulate STXBP1, a causative gene for infantile epilepsy syndrome and an essential factor for synapse vesicle release, via their direct interaction. In addition, our analysis suggests that Syt1 plays a role specifically in HFD for 1 week. HFD-induced AS isoforms of CASK, Cacnb1, Cyfip2 and Syt1 impair pre-synapse vesicle release in primary neurons. AAV-PQBP1, AAV-CASK, AAV-Cacnb1, AAV-Cyfip2 or AAV-Syt1 rescues synapse and/or cognitive dysfunctions in HFD mice, genetically supporting the pathological PQBP1-presynapse axis in HFD. Moreover, immunohistochemistry experiments suggest that the pathological axis plays roles not only in excitatory neurons, but also in inhibitory neurons of the brain. Collectively, our results unravel a novel molecular mechanism for brain dysfunction when mice are exposed to a HFD.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.